How much funding has Synvect raised?

Synvect has raised $3.0M in total funding, most recently a Seed round.

Who are Synvect's investors?

Synvect's investors include Bill & Melinda Gates Foundation, Antler, NuFund Venture Group, Redbud VC.

Where is Synvect headquartered?

Synvect is headquartered in La Jolla, California, United States.

What industry is Synvect in?

Synvect operates in Healthcare, Biotech, Deep Tech.

Synvect

Eco-friendly mosquito control powered by CRISPR

La Jolla, United States · Founded 2024 · $3.0M raised

Healthcare

Biotech

Deep Tech

Headquarters: La Jolla, California
Founded: 2024
Business Model: B2B
Website: synvect.com

Total Funding: $3.0M
Last Round: $3.0M SeedMar 2025
Rounds: 1

About

Synvect is a CRISPR-based biotechnology company developing an eco-friendly, effective, and evolutionary stable mosquito control platform. Built on 15 years of cutting-edge research and $20M in prior academic funding, the company's next-generation Sterile Insect Technique (ngSIT) technology leverages bioengineered mosquitoes to suppress disease-carrying populations without pesticides or environmental harm. Synvect targets the growing global burden of mosquito-borne diseases such as malaria, dengue, and Zika.

Summary

Synvect is a Healthcare company based in La Jolla, United States, founded in 2024. It has raised $3.0M in total across 1 round, most recently a $3.0M Seed round in Mar 2025. Investors include Bill & Melinda Gates Foundation, Antler and NuFund Venture Group.